Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Maruho North America Inc.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Who are able and willing to give signed informed consent
Who are male or females aged 18 years or older with plaque psoriasis confirmed by the Investigator.
Who have up to 20% of body surface area (BSA) afflicted with plaques
Who are neither pregnant nor breast-feeding, nor plan to become pregnant during the study.
You may not be if
Who have a history of allergy to vitamin D3 derivative preparations or a history of relevant drug hypersensitivity.
Who are pregnant or lactating.
Who have any renal or hepatic insufficiency, or clinically significant cardiac, renal or hepatic disease.
Who are not deemed eligible as determined by medical history, physical examination or clinical laboratory safety tests.
Who have clinically relevant history or presence of any disease or surgical history other than psoriasis which is likely to affect the conduct of the study.
Whose serum calcium levels exceed the upper limit of reference range
Who have used any investigational medicinal product and/or participated in any clinical study within 60 days of treatment.
Who have been treated with systemic therapy within 30days of treatment.
Who have treated with biologics within 5 half-lives of the biologics before the day of treatment
Who have been treated with topical therapy within 14days before the day of treatment.
Clareo Health | Long Term Study to Evaluate Safety and Efficacy of M518101 in Subjects With Plaque Psoriasis
